pharma news today glp-1 GLP-1s and the Unintended Consequences of the $100 Billion Market GLP-1 Pipeline Update: August 2025

NuMedica Appe-Curb combines multiple ingredients commonly used in routines focused on cravings, mood, and behavioral wellness patterns

Lancet Glob Health 12:e1534e1543

Formulato per la tua linea La carnitina un derivato aminoacidico prodotto dal nostro corpo a partire da due aminoacidi, la lisina e la metionina

MBX 4291, dual GLP-1/GIP co-agonist prodrug designed for potential once-monthly dosing and improved tolerability in obesity Recent Highlights: In June 2026, MBX Biosciences announced data that demonstrated sustained benefit of its once-weekly Canvuparatide as a potential PTH replacement therapy in chronic hypoparathyroidism